F Bio N Tech Se Transaction History

F

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$123.25 - $186.24 $161,827 - $244,533	1,313 New	1,313 $296,000
Q4 2021 Feb 04, 2022	SELL	$216.64 - $362.52 $290,514 - $486,139	-1,341 Closed	0 $0
Q3 2021 Nov 01, 2021	BUY	$205.93 - $447.23 $5,766 - $12,522	28 Added 2.13%	1,341 $366,000
Q2 2021 Aug 10, 2021	BUY	$113.32 - $241.49 $148,789 - $317,076	1,313 New	1,313 $293,000

356

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of F, based on Form 13F filings with the SEC.

Stay updated on F with notifications on news.